In this episode we break down skin substitutes for diabetic foot ulcers: how they work biologically, why they are not interchangeable, and common errors clinicians make.
We review major categories and examples (bioengineered cellular grafts like Apligraf and Dermagraft; human dermal matrices like AlloDerm and GraftJacket; placental/amniotic products like EpiFix and Grafix; xenografts such as Integra; and synthetic matrices like OASIS), plus inclusion/exclusion criteria.
Practical application rules are emphasized: sharp debridement to bleeding tissue, infection control, optimized perfusion, strict offloading, proper dressing, and documentation. Stop after 2–3 failed applications and remember grafts are tools—not cures.
Fler avsnitt av Diabetic Foot Files
Visa alla avsnitt av Diabetic Foot FilesDiabetic Foot Files med Diabetic Foot Files finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
